Evidence map›Paper›PMID 33906946›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Blood-brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses.

Scott R Burks, Cymon N Kersch, Jaclyn A Witko, Michael A Pagel, Maggie Sundby, Leslie L Muldoon, Edward A Neuwelt, Joseph A Frank

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Scott R BurksFrank Laboratory, Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD 20895; scott.burks@nih.gov jfrank@cc.nih.gov.
Cymon N KerschDepartment of Neurology, Oregon Health & Science University, Portland, OR 97239.
Jaclyn A WitkoFrank Laboratory, Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD 20895.ORCID 0000-0002-2443-1660
Michael A PagelDepartment of Neurology, Oregon Health & Science University, Portland, OR 97239.
Maggie SundbyFrank Laboratory, Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD 20895.
Leslie L MuldoonDepartment of Neurology, Oregon Health & Science University, Portland, OR 97239.ORCID 0000-0001-5583-2304
Edward A NeuweltDepartment of Neurology, Oregon Health & Science University, Portland, OR 97239.ORCID 0000-0002-6679-6203
Joseph A FrankFrank Laboratory, Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD 20895; scott.burks@nih.gov jfrank@cc.nih.gov.ORCID 0000-0001-8636-7273
Oregon Health & Science University · USNational Institutes of Health Clinical Center · USNational Institute of Biomedical Imaging and Bioengineering · US

Funding

Two Compartment Models to Improve Brain Tumor TherapyR01CA137488 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NEUWELT, EDWARD A. · 2008 to 2019
$7.3M
Opening of the Blood-Brain Barrier to Antitumor AgentsR01CA199111 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NEUWELT, EDWARD A. · 2016 to 2020
$3.1M
Preclinical high intensity focused ultrasound: mechanisms and applicationsZIACL040014 · CLC · CLINICAL CENTER · PI FRANK, JOSEPH · 2009 to 2025
$0k
Chemoprotection and imaging for aminoglycoside and chemotherapy toxicitiesI01BX003897 · VA · PORTLAND VA MEDICAL CENTER · PI NEUWELT, EDWARD A. · 2018 to 2021
–
BLRD VA I01 BX003897NCI NIH HHS R01 CA137488NCI NIH HHS R01 CA199111
6 · The paper itself

Abstract

Intracarotid arterial hyperosmolar mannitol (ICAHM) blood-brain barrier disruption (BBBD) is effective and safe for delivery of therapeutics for central nervous system malignancies. ICAHM osmotically alters endothelial cells and tight junction integrity to achieve BBBD. However, occurrence of neuroinflammation following hemispheric BBBD by ICAHM remains unknown. Temporal proteomic changes in rat brains following ICAHM included increased damage-associated molecular patterns, cytokines, chemokines, trophic factors, and cell adhesion molecules, indicative of a sterile inflammatory response (SIR). Proteomic changes occurred within 5 min of ICAHM infusion and returned to baseline by 96 h. Transcriptomic analyses following ICAHM BBBD further supported an SIR. Immunohistochemistry revealed activated astrocytes, microglia, and macrophages. Moreover, proinflammatory proteins were elevated in serum, and proteomic and histological findings from the contralateral hemisphere demonstrated a less pronounced SIR, suggesting neuroinflammation beyond regions of ICAHM infusion. Collectively, these results demonstrate ICAHM induces a transient SIR that could potentially be harnessed for neuroimmunomodulation.

Indexed as

AnimalsBlood-Brain BarrierCarotid ArteriesCell AdhesionCell Adhesion MoleculesCentral Nervous System NeoplasmsChemokinesCytokinesEndothelial CellsHumansImmunity, InnateInflammationMannitolRatsTight JunctionsCell Adhesion MoleculesChemokinesCytokinesMannitolblood–brain barrierhyperosmolar mannitolneuroinflammationsterile inflammation

Identifiers

PMID33906946
PMCPMC8106347
OpenAlexW3158706008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.